We analyzed independent prognostic factors associated with survival and risk of evolution to acute leukemia in our series of 83 patients with previously untreated chronic myelomonocytic leukemia (CMML), with the aim of testing the validity of the stratification based on white blood cell (WBC) count, in myeloproliferative and myelodysplastic types of the revisited WHO classification.